雅虎香港 搜尋

登入

搜尋結果

  1. 285.800
    加入追蹤清單
    +20.200 (+7.61%)
    收市時間: 2024年5月10日, 週五 下午 4:08 HKT · (HKD)。延遲價格。市場已收市。
    全螢幕顯示
    • 前收市價
      265.600
      開市
      275.000
      買盤
      285.600
      賣出價
      285.800
    • 今日波幅
      274.000 - 287.400
      52週波幅
      212.200 - 336.000
      成交量
      21.26M
      平均成交量
      6.13M
    • 市值
      362.35B
      Beta值 (5年，每月)
      0.86
      市盈率 (最近12個月)
      31.76
      每股盈利 (最近12個月)
      9.000
    • 業績公佈日
      2024-04-24
      遠期股息及收益率
      7.82 & 2.74%
      除息日
      2024-03-13
      1年預測目標價
      301.96

    查看更多0388.HK

    相關股票

    查看全部

  2. www.mims.com › hongkong › companyPrimal Products & Contact Information | MIMS Hongkong

    Packing/Price. 1000's ($1,500.00/pack) MIMS Class. Calcium Antagonists, Anti-Anginal Drugs. ATC Classification. C08DB01 - diltiazem : Belongs to the class of benzothiazepine derivative selective calcium-channel blockers with direct cardiac effects. Used in the treatment of cardiovascular diseases.

  3. www.mims.com › hongkong › companySandoz Additional Info | MIMS Hongkong

    SANDOZ HONG KONG LIMITED. Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical need. Our ambition is to be the world's leading and most valued generics company.

    • Rm 30-101, 30/F, The Gateway Tower 515 Canton RdTsim Sha TsuiHong Kong
    • 2881 5811

  4. www.mims.com › hongkong › drugAdvanced Drug Search | MIMS Hong Kong

    Search drug information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India Register for a MIMS account and ...

  5. www.mims.com › hongkong › companySanofi Additional Info | MIMS Hongkong

    Sanofi Hong Kong is part of Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: Diabetes Solutions, Human Vaccines, Innovative Drugs, Rare Diseases, Consumer Healthcare, Emerging ...

  6. www.mims.com › hongkong › companyPharmason Additional Info | MIMS Hongkong

    Mailing Address. 16th Floor, Ever Gain Centre. 28 On Muk Street. Shatin Hong Kong.

  7. www.mims.com › hongkong › companyNexpharm Products & Contact Information | MIMS Hongkong

    Cenex cap 200 mg. celecoxib. Packing/Price. 10 × 10's. MIMS Class. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) ATC Classification. M01AH01 - celecoxib : Belongs to the class of non-steroidal antiinflammatory and antirheumatic products, coxibs. Featured Products of Nexpharm: Cenex.

  8. www.mims.com › hongkong › drugTagrisso Dosage & Drug Information | MIMS Hong Kong

    Tagrisso FC tab 40 mg. Packing/Price. 30's. Form. Tagrisso FC tab 80 mg. Packing/Price. 30's. Tagrisso (Osimertinib mesylate): Adjuvant treatment after complete tumour resection in adults w/ stage IB-IIIA NSCLC whose tumours have epidermal growth fac.